Evidence Hub

Is there a way to overcome oversedation in a patient being treated with clozapine?

T. I. Prior

Journal of Psychiatry & Neuroscience, 2002

18 participants

Abstract

The pharmacologic management of schizophrenia has changed over the past decade through the introduction of new medications with generally fewer side effects than the older antipsychotics. Unfortunately, some patients do not respond to the second-generation antipsychotics. In this situation, a trial of clozapine may be undertaken. However, although schizophrenic symptoms may be alleviated, the patients often continue to suffer psychologically and socially because of the side effects of clozapine. One of these so-called “nuisance” side effects is sedation, and one result of oversedation is an inability to participate in rehabilitation programs aimed at improving social skills, social integration and interpersonal relationships.

Coincidentally, there has been an increase in our understanding of the role of cytochrome P450 (CYP) enzymes in the mechanisms of the side effects related to concomitant use of medications. For example, an increase in the serum concentration of clozapine is a well-known result of concomitant use of fluvoxamine. This effect is believed to result from inhibition of the activity of CYP1A2 by fluvoxamine and can lead to concentration-dependent clozapine-related side effects such as sedation, orthostatic hypotension and seizures.

Although interactions between medications at the level of the CYPs are viewed primarily in the context of negative treatment outcomes, it may be possible to exploit such interactions for the benefit of patients. Two recent reports…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free